China Healthwise Holdings (HKSE:00348) 3-Year Revenue Growth Rate : 2.20% (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is China Healthwise Holdings 3-Year Revenue Growth Rate?

China Healthwise Holdings's Revenue per Share for the six months ended in Dec. 2023 was HK$0.09.

During the past 12 months, China Healthwise Holdings's average Revenue per Share Growth Rate was 3.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 2.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was -25.40% per year. During the past 10 years, the average Revenue per Share Growth Rate was -11.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of China Healthwise Holdings was 16.60% per year. The lowest was -42.80% per year. And the median was -18.10% per year.

Competitive Comparison of China Healthwise Holdings's 3-Year Revenue Growth Rate

For the Pharmaceutical Retailers subindustry, China Healthwise Holdings's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Healthwise Holdings's 3-Year Revenue Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, China Healthwise Holdings's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where China Healthwise Holdings's 3-Year Revenue Growth Rate falls into.

China Healthwise Holdings 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

China Healthwise Holdings (HKSE:00348) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

China Healthwise Holdings 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of China Healthwise Holdings's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

China Healthwise Holdings (HKSE:00348) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Healthwise Holdings Ltd (HKSE:00348) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

168-200 Connaught Road Central, Unit 1209, Shun Tak Centre, West Tower, Hong Kong, HKG

Website

http://www.healthwisehk.com/en

China Healthwise Holdings Ltd is an investment holding company. It operates in three segments: Chinese health products, Money lending business, and investment in financial instruments. The majority of its revenue comes from trading in Chinese health products, which include pharmaceutical products, ginseng, and dried seafood products. The company's geographical segments are Hong Kong and the PRC, of which key revenue is derived from Hong Kong.

China Healthwise Holdings (HKSE:00348) Headlines

No Headlines